AMANDA COX: Open Payments
NPI 1801173604 · LEWISBERRY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 93 payments from 18 companies in 2025. Trend: 2023 $1,901 · 2024 $1,234 · 2025 $1,659
Food & beverage: $1,659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $297 |
| Novo Nordisk Inc | 15 | $213 |
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| Exact Sciences Corporation | 5 | $154 |
| PFIZER INC. | 10 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $93 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Dexcom, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 4 | $62 |
Products named: ELIQUIS, The Cologuard Plus Collection Kit, AIRSUPRA, QULIPTA, UBRELVY, Wegovy, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
